Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson’s disease: A 3T and 7T MRI study

Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson’s disease: A 3T and 7T MRI study

Degeneration in the substantia nigra (SN) pars compacta (SNc) underlies motor symptoms in Parkinson’s disease (PD). Currently, there are no neuroimaging biomarkers that are sufficiently sensitive, specific, reproducible, and accessible for routine diagnosis or staging of PD. Although iron is essenti...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Erind Alushaj, Nicholas Handfield-Jones, Alan Kuurstra, Anisa Morava, Ravi S. Menon, Adrian M. Owen, Manas Sharma, Ali R. Khan, Penny A. MacDonald
Format:	Artykuł
Język:	English
Wydane:	Elsevier 2024-01-01
Seria:	NeuroImage: Clinical
Hasła przedmiotowe:	Parkinson’s disease Neuroimaging Quantitative susceptibility mapping Iron Midbrain
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S2213158224000160

Podobne zapisy

Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
od: Valeria V. Goloborshcheva, i wsp.
Wydane: (2022-09-01)

Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
od: Gian-Carlo Eyer, i wsp.
Wydane: (2021-11-01)

Identification and electrophysiology of isolated pars compacta neurons from guinea-pig substantia nigra.
od: Hainsworth, A, i wsp.
Wydane: (1991)

SYNAPTIC AND DENDRITIC CORRELATES OF HETEROGENEOUS ACTIVITY OF DOPAMINERGIC NEURONS IN THE SUBSTANTIA NIGRA PARS COMPACTA
od: Henny, P, i wsp.
Wydane: (2011)

Segmentation of Substantia Nigra in Brain Parenchyma Sonographic Images Using Deep Learning
od: Giansalvo Gusinu, i wsp.
Wydane: (2023-12-01)

Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compacta
od: William S. Conrad, i wsp.
Wydane: (2024-12-01)

Evidence for direct dopaminergic connections between substantia nigra pars compacta and thalamus in young healthy humans
od: Giovanni Cirillo, i wsp.
Wydane: (2025-01-01)

Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide
od: Yazmin M. Flores-Martinez, i wsp.
Wydane: (2018-01-01)

Anterograde trans-neuronal labeling of striatal interneurons in relation to dopamine neurons in the substantia nigra pars compacta
od: Fuyuki Karube, i wsp.
Wydane: (2024-02-01)

Cell-attached and Whole-cell Patch-clamp Recordings of Dopamine Neurons in the Substantia Nigra Pars Compacta of Mouse Brain Slices
od: Stefano Cattaneo, i wsp.
Wydane: (2021-08-01)

Neurotransmitter accumulation and Parkinson's disease‐like phenotype caused by anion channelrhodopsin opto‐controlled astrocytic mitochondrial depolarization in substantia nigra pars compacta
od: Sen‐Miao Li, i wsp.
Wydane: (2024-06-01)

PARKINSON BY ACUTE DOPAMINE RECEPTORS BLOCKADE, OR 6-OHDA LESION IN SUBSTANTIA NIGRA PARS COMPACTA, PRODUCES CHANGES IN CORTICAL OSCILLATIONS AND NETWORK DYNAMICS
od: Aidan Alejandro Ortega García, i wsp.
Wydane: (2023-10-01)

A rapid multi-parametric quantitative MR imaging method to assess Parkinson’s disease: a feasibility study
od: Min Duan, i wsp.
Wydane: (2024-03-01)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
od: Sayyed Shahid Hussain, i wsp.
Wydane: (2023-08-01)

Substantia nigra alterations in mice modeling Parkinson’s disease
od: I. N. Rozhkova, i wsp.
Wydane: (2024-11-01)

Neuronal Firing and Glutamatergic Synapses in the Substantia Nigra Pars Reticulata of LRRK2-G2019S Mice
od: Giacomo Sitzia, i wsp.
Wydane: (2022-11-01)

Investigation of non-cholinergic acetylcholinesterase, and related peptides in an in vitro preparation of the substantia nigra
od: Whyte, K, i wsp.
Wydane: (2001)

A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson’s disease mouse model
od: Chong-Lei Fu, i wsp.
Wydane: (2024-01-01)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
od: Helena Xicoy, i wsp.
Wydane: (2020-08-01)

Structural Connectivity-Based Parcellation of the Dopaminergic Midbrain in Healthy Subjects and Schizophrenic Patients
od: Gianpaolo Antonio Basile, i wsp.
Wydane: (2020-12-01)

Single-cell sequencing of the substantia nigra reveals microglial activation in a model of MPTP
od: Qing Liu, i wsp.
Wydane: (2024-06-01)

Heterogeneous somatostatin-expressing neuron population in mouse ventral tegmental area
od: Nagaeva, Elina, i wsp.
Wydane: (2020)

Leigh′s disease (subacute necrotising encephalo-myelopathy)-a case report
od: AG Hombal, i wsp.
Wydane: (2005-04-01)

Zona incerta distributes a broad movement signal that modulates behavior
od: Sebastian Hormigo, i wsp.
Wydane: (2023-12-01)

Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson’s disease and its clinical implications
od: Yuan-yuan Zhang, i wsp.
Wydane: (2024-07-01)

Topographical metal burden correlates with brain atrophy and clinical severity in Wilson's disease
od: Sung-Pin Fan, i wsp.
Wydane: (2024-10-01)

Auditory oddball responses in the human subthalamic nucleus and substantia nigra pars reticulata
od: Dallas Leavitt, i wsp.
Wydane: (2024-06-01)

Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
od: Maria Regoni, i wsp.
Wydane: (2021-05-01)

EFFECT OF Zanthoxylum acanthopodium DC EXTRACT ON THE INCREASE OF BRAIN CELLS IN THE SUBSTANTIA NIGRA OF WISTAR RATS THAT ARE ROTENONE-INDUCED
od: Shalli hafizha, i wsp.
Wydane: (2024-12-01)

Picornavirus May Be Linked to Parkinson’s Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra
od: Bo Niklasson, i wsp.
Wydane: (2022-03-01)

Preclinical studies and transcriptome analysis in a model of Parkinson’s disease with dopaminergic ZNF746 expression
od: Ji Hun Kim, i wsp.
Wydane: (2025-02-01)

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
od: Sang‐Min Oh, i wsp.
Wydane: (2015-03-01)

Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
od: Qi Zhang, i wsp.
Wydane: (2024-09-01)

Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata.
od: Threlfell, S, i wsp.
Wydane: (2004)

Genetic inactivation of alpha-synuclein affects embryonic development of dopaminergic neurons of the substantia nigra, but not the ventral tegmental area, in mouse brain
od: Tatiana V. Tarasova, i wsp.
Wydane: (2018-05-01)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
od: Qiang Liu, i wsp.
Wydane: (2023-08-01)

Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
od: Sarah Plum, i wsp.
Wydane: (2020-12-01)

TREM-1 mediates interaction between substantia nigra microglia and peripheral neutrophils
od: Tong Shen, i wsp.
Wydane: (2024-01-01)

Microvascularization of the Midbrain in Lylei's Flying Fox (Pteropus lylei)
od: Sirinush Sricharoenvej, i wsp.
Wydane: (2003-11-01)

Micrographia after midbrain infarction alleviated by Japanese calligraphy-style writing: A case report
od: Kazutaka Sakamoto, i wsp.
Wydane: (2024-01-01)